FR2381058A1 - Glycoproteines specifiques des tumeurs et procede pour la detection des cancers tumorigenes - Google Patents

Glycoproteines specifiques des tumeurs et procede pour la detection des cancers tumorigenes

Info

Publication number
FR2381058A1
FR2381058A1 FR7804614A FR7804614A FR2381058A1 FR 2381058 A1 FR2381058 A1 FR 2381058A1 FR 7804614 A FR7804614 A FR 7804614A FR 7804614 A FR7804614 A FR 7804614A FR 2381058 A1 FR2381058 A1 FR 2381058A1
Authority
FR
France
Prior art keywords
tumor
tumorigenous
cancers
detection
serum
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7804614A
Other languages
English (en)
French (fr)
Other versions
FR2381058B1 (enExample
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Research Corp
Original Assignee
Research Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Research Corp filed Critical Research Corp
Publication of FR2381058A1 publication Critical patent/FR2381058A1/fr
Application granted granted Critical
Publication of FR2381058B1 publication Critical patent/FR2381058B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • G01N33/5756—
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/804—Radioisotope, e.g. radioimmunoassay
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/825—Pretreatment for removal of interfering factors from sample
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/806—Antigenic peptides or proteins
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/828—Cancer
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/829—Blood
    • Y10S530/83—Plasma; serum

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FR7804614A 1977-02-18 1978-02-17 Glycoproteines specifiques des tumeurs et procede pour la detection des cancers tumorigenes Granted FR2381058A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/770,103 US4146603A (en) 1977-02-18 1977-02-18 Tumor specific glycoproteins and method for detecting tumorigenic cancers

Publications (2)

Publication Number Publication Date
FR2381058A1 true FR2381058A1 (fr) 1978-09-15
FR2381058B1 FR2381058B1 (enExample) 1983-03-18

Family

ID=25087489

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7804614A Granted FR2381058A1 (fr) 1977-02-18 1978-02-17 Glycoproteines specifiques des tumeurs et procede pour la detection des cancers tumorigenes

Country Status (8)

Country Link
US (1) US4146603A (enExample)
JP (2) JPS53127822A (enExample)
CA (1) CA1087979A (enExample)
CH (2) CH658317A5 (enExample)
DE (1) DE2806146C2 (enExample)
FR (1) FR2381058A1 (enExample)
GB (1) GB1591561A (enExample)
IT (1) IT1102384B (enExample)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2480122A1 (fr) * 1980-04-11 1981-10-16 Kureha Chemical Ind Co Ltd Procede de preparation d'une glycoproteine a activite immunosupressive, glycoproteine telle qu'ainsi obtenue et medicament la renfermant
EP0162977A3 (en) * 1984-05-02 1986-12-30 University Patents, Inc. Enzyme immunoassay for cancer procoagulant

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4379839A (en) * 1977-05-23 1983-04-12 The Trustees Of Columbia University In The City Of New York Method for detecting cancer
SE451508B (sv) * 1979-01-30 1987-10-12 Otsuka Pharma Co Ltd Bestemning av substanser med tumorassocierade glykobindningar medelst lektiner som specifikt binder till terminala galaktos (beta 1 - 3 eller beta 1 - 4)-n-acetylglukosamin- eller -n-acetylgalaktosamingrupper samt cance
WO1980002459A1 (en) * 1979-04-30 1980-11-13 Immunology Dev Corp New and improved methodology for the immunodiagnosis of multiple sclerosis and/or malignant diseases from blood sample analysis
US4311686A (en) * 1979-04-30 1982-01-19 The Immunology Development Corporation Methodology for the immunodiagnosis of multiple sclerosis and/or malignant diseases from blood sample analysis
US4361544A (en) * 1980-03-03 1982-11-30 Goldenberg Milton David Tumor localization and therapy with labeled antibodies specific to intracellular tumor-associated markers
US4331647A (en) * 1980-03-03 1982-05-25 Goldenberg Milton David Tumor localization and therapy with labeled antibody fragments specific to tumor-associated markers
US4460561A (en) * 1980-03-03 1984-07-17 Goldenberg M David Tumor localization and therapy with labeled antibodies specific to intracellular tumor-associated markers
EP0035265B1 (en) * 1980-03-03 1986-01-02 Milton David Goldenberg Agent for tumor localization and therapy with labeled antibodies and antibody fragments
US4409200A (en) * 1980-04-28 1983-10-11 Research Corporation Reverse transcriptase from human milk, method for its purification, and its use in the detection of breast cancer
JPS5729949A (en) * 1980-07-30 1982-02-18 Nippon Koutai Kenkyusho:Kk Determination of sugar branch related to cancer and diagnostic technique of cancer
US4406830A (en) * 1981-04-17 1983-09-27 Shanksville Corporation, N.V. Regulatory glycoprotein for immune response and the use thereof in the production of T-cell growth factor
US4342567A (en) * 1981-07-06 1982-08-03 Sloan Kettering Institute For Cancer Research Sialic acid determination method
EP0085254A1 (en) * 1981-12-28 1983-08-10 Yoshio Sakagami Proteins and their extraction
GB2114287B (en) * 1982-01-29 1985-10-30 Otsuka Pharma Co Ltd Process for determining tumor-associated glycolinkage
ZW7583A1 (en) * 1982-04-07 1983-06-29 Baylor College Medicine Products and methods for treatment of cancer
JPS5990052A (ja) * 1982-11-16 1984-05-24 Katsu Taniguchi モノクロ−ナル特異抗体を用いたメラノ−マ診断薬
US4916213A (en) * 1983-02-22 1990-04-10 Xoma Corporation Ribosomal inhibiting protein-immunoglobulin conjugates with specificity for tumor cell surface antigens, and mixtures thereof
US4493898A (en) * 1983-04-25 1985-01-15 Purdue Research Foundation Method for detecting and monitoring cancer
US4524026A (en) * 1983-08-29 1985-06-18 Yoshio Sakagami Novel proteinous cancer-cell proliferation inhibitory factors
EP0155938A1 (en) * 1983-09-28 1985-10-02 Summa Medical Corporation Lectin composition and method for diagnosis of cancer
IT1174800B (it) * 1983-11-21 1987-07-01 Alberto Bartorelli Metodo per la determinazione di immunoglobuline umane specifiche per gli antigeni dei carcinomi umani e sua utilizzazione nella sierodiognosi di forme primitive tumorali
US4748128A (en) * 1984-03-30 1988-05-31 Dianon Systems, Inc. Method for determining lipid bound sialic acid in plasma
JPS60214737A (ja) * 1984-04-06 1985-10-28 Nippon Koutai Kenkyusho:Kk 糖鎖関連抗原の製造法
US4801475A (en) * 1984-08-23 1989-01-31 Gregory Halpern Method of hydrophilic coating of plastics
US4663233A (en) * 1985-10-24 1987-05-05 Universal High Technologies Lens with hydrophilic coating
US5091178A (en) * 1986-02-21 1992-02-25 Oncogen Tumor therapy with biologically active anti-tumor antibodies
CA1335883C (en) * 1986-07-08 1995-06-13 Bryan Michael Longenecker Enhancement of the cellular immune response
CA1340927C (en) * 1987-10-09 2000-03-14 Peter S. Linsley Method for increasing the sensitivity of assays for target ligand
US5296346A (en) * 1990-11-19 1994-03-22 Nonda Katopodis Method for determining lipid bound sialic acid in plasma
KR101077275B1 (ko) 2009-05-07 2011-10-27 한국기초과학지원연구원 당단백질의 당쇄화를 이용한 암 진단 방법
KR101100809B1 (ko) * 2009-12-29 2012-01-02 한국기초과학지원연구원 암 진단용 펩티드 마커 및 이를 이용한 암 진단방법
KR101143891B1 (ko) 2009-12-29 2012-05-11 한국기초과학지원연구원 단백질의 비정상적인 당쇄화를 이용하는 암진단 마커
CN109799331A (zh) * 2019-03-18 2019-05-24 湖南海源医疗科技股份有限公司 一种恶性肿瘤特异性生长因子tsgf分析试条

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2095644A5 (enExample) * 1970-06-01 1972-02-11 Hoffmann La Roche
FR2191885A1 (enExample) * 1972-07-10 1974-02-08 Bjorklund Knut
US3956258A (en) * 1972-05-12 1976-05-11 Hoffmann-La Roche Inc. Carcinoembryonic antigens
FR2289205A1 (fr) * 1974-10-30 1976-05-28 Baekgaardosther Kurt Nouvelles proteines associees aux cancers humains et derives correspondants utilises pour le traitement et le diagnostic du cancer

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3663684A (en) * 1970-06-01 1972-05-16 Hoffmann La Roche Carcinoembryonic antigen and diagnostic method using radioactive iodine
CH583036A5 (enExample) * 1972-05-12 1976-12-31 Hoffmann La Roche
US4010251A (en) * 1974-12-16 1977-03-01 Green Allan M Scanning agent composition and use in imaging liver and for biliary function

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2095644A5 (enExample) * 1970-06-01 1972-02-11 Hoffmann La Roche
US3956258A (en) * 1972-05-12 1976-05-11 Hoffmann-La Roche Inc. Carcinoembryonic antigens
FR2191885A1 (enExample) * 1972-07-10 1974-02-08 Bjorklund Knut
FR2289205A1 (fr) * 1974-10-30 1976-05-28 Baekgaardosther Kurt Nouvelles proteines associees aux cancers humains et derives correspondants utilises pour le traitement et le diagnostic du cancer

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
EXBK/78 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2480122A1 (fr) * 1980-04-11 1981-10-16 Kureha Chemical Ind Co Ltd Procede de preparation d'une glycoproteine a activite immunosupressive, glycoproteine telle qu'ainsi obtenue et medicament la renfermant
EP0162977A3 (en) * 1984-05-02 1986-12-30 University Patents, Inc. Enzyme immunoassay for cancer procoagulant

Also Published As

Publication number Publication date
US4146603A (en) 1979-03-27
IT7848072A0 (it) 1978-02-16
CA1087979A (en) 1980-10-21
DE2806146C2 (de) 1984-01-26
GB1591561A (en) 1981-06-24
JPS6218869B2 (enExample) 1987-04-24
FR2381058B1 (enExample) 1983-03-18
CH658317A5 (de) 1986-10-31
DE2806146A1 (de) 1978-08-24
JPS60155975A (ja) 1985-08-16
CH648330A5 (de) 1985-03-15
IT1102384B (it) 1985-10-07
JPS53127822A (en) 1978-11-08
JPS6129464B2 (enExample) 1986-07-07

Similar Documents

Publication Publication Date Title
FR2381058A1 (fr) Glycoproteines specifiques des tumeurs et procede pour la detection des cancers tumorigenes
Tsao et al. Differential effects of sodium butyrate, dimethyl sulfoxide, and retinoic acid on membrane-associated antigen, enzymes, and glycoproteins of human rectal adenocarcinoma cells
Nunez et al. Comparative study on the binding of estrogens by human and rat serum proteins in development
Goldwasser et al. Purification of erythropoietin
ABELSON et al. Selective interruption of high molecular weight RNA synthesis in HeLa cells by camptothecin
Stravalaci et al. Specific recognition of biologically active amyloid-β oligomers by a new surface plasmon resonance-based immunoassay and an in vivo assay in Caenorhabditis elegans
Mendelsohn et al. Identification of the vitamin B12-binding protein in the serum of normals and of patients with chronic myelocytic leukemia
FR2443062A1 (fr) Detection rapide des bacteries
Haut et al. The nonhemoglobin erythrocytic proteins, studied by electrophoresis on starch gel
Benassayag et al. Isolation of two forms of rat alpha-fetoprotein and comparison of their binding parameters with estradiol-17β
MASAKI et al. “M-substance”, a new protein constituting the M-line of myofibrils
Gergely et al. Structural studies of immunoglobulins—II the varying susceptibility to papain-digestion of a group of human myeloma γG-globulins
Lane et al. Effect of the proline analogue azetidine-2-carboxylic acid on collagen synthesis in vivo II. Morphological and physical properties of collagen containing the analogue
Graesslin et al. The microheterogeneity of human chorionic gonadotropin (HCG) reflected in the β-subunits
Bloodgood Preferential turnover of membrane proteins in the intact Chlamydomonas flagellum
Barre et al. Decreased alpha 1-acid glycoprotein in liver cirrhosis: consequences for drug protein binding
Fothergill et al. Purification of Fluorescent Protein Conjugates: Comparison of Charcoal and ‘Sephadex’
Jansen et al. Regulation of lipoprotein lipase immunological study of adipose tissue
Rowland et al. Myoglobin and muscular dystrophy: Electrophoretic and immunochemical study
Pfeffer et al. Human chorionic gonadotropin inhibits Kaposi’s sarcoma associated angiogenesis, matrix metalloprotease activity, and tumor growth
Delpech et al. Etude immunochimique et immunologique des tumeurs du cerveau humain
Tanaka et al. The crystallization of mitochondrial cytochrome oxidase-cytochrome c complex
Kalant et al. Glomerular basement membrane in experimental nephrosis: x-ray diffraction and electrophoretic studies
Mullins et al. Isolation and characterization of a plasma membrane fraction derived from the luminal surface of the pig uterus during the estrous cycle and early pregnancy
Scott et al. Reactive oxygen species in experimental allergic encephalomyelitis

Legal Events

Date Code Title Description
ST Notification of lapse